Caption Management’s Kura Oncology KURA Stock Holding History

Caption Management’s Portfolio KURA Stock Details KURA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-111,023	Closed	-$1.17M	–	1402
2023 Q2	$1.17M	Buy	+111,023	New	+$1.31M	0.02%	628
2022 Q3	–	Sell	-11,518	Closed	-$178K	–	1692
2022 Q2	$211K	Sell	11,518 -53,482	-82%	-$769K	﹤0.01%	1224
2022 Q1	$1.04M	Sell	65,000 -92,000	-59%	-$1.33M	0.01%	956
2021 Q4	$2.2M	Buy	+157,000	New	+$2.54M	0.02%	753
2021 Q3	–	Sell	-4,600	Closed	-$86.7K	–	1654
2021 Q2	$96K	Buy	+4,600	New	+$114K	﹤0.01%	1220
2021 Q1	–	Sell	-28,390	Closed	-$927K	–	1238
2020 Q4	$927K	Buy	+28,390	New	+$998K	0.02%	628

Other funds holding KURA

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

SCM

Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return

Caption Management's KURA Position: Q3 2023 in Review

Caption Management sold out of Kura Oncology (KURA) in Q3 2023, closing a stake of 111,023 shares — an estimated $1.17M sold.

Caption Management first reported a position in KURA in Q4 2020 and held it in 6 quarters. The position peaked at $2.2M in Q4 2021. 133 funds tracked by Wall St. Rank hold KURA as of Q3 2023.

Caption Management reported no remaining Kura Oncology position as of Q3 2023 after selling out during the quarter.
Caption Management sold 111,023 Kura Oncology shares in Q3 2023, an estimated $1.17M.
Caption Management first reported a position in Kura Oncology in Q4 2020 and held it in 6 quarters.
Caption Management's Kura Oncology position peaked at $2.2M in Q4 2021.
133 funds tracked by Wall St. Rank held Kura Oncology as of Q3 2023.

Based on Caption Management's 13F filing for Q3 2023, filed 14 Nov 2023.